Trevi Therapeutics | DEFA14A: Others
Apr 26 16:50 ET
Trevi Therapeutics | DEF 14A: Definitive information statements
Apr 26 16:45 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
Mar 20 16:16 ET
Trevi Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 20 16:13 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
Nov 9, 2023 16:08 ET
Trevi Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Aug 11, 2023 16:06 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update
Aug 10, 2023 16:08 ET
Trevi Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Jun 29, 2023 17:06 ET
Trevi Therapeutics | 8-K: Current report
Jun 29, 2023 16:02 ET
Trevi Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 11, 2023 16:16 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023 16:09 ET
Trevi Therapeutics | DEFA14A: Others
May 1, 2023 16:03 ET
Trevi Therapeutics | DEF 14A: Definitive proxy statements
May 1, 2023 16:02 ET
Trevi Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Apr 14, 2023 16:26 ET
Trevi Therapeutics | 8-K: Current report
Apr 14, 2023 16:01 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
Mar 16, 2023 16:11 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
Nov 10, 2022 16:08 ET
Trevi Therapeutics | 8-K: Current report
Sep 23, 2022 09:23 ET
Trevi Therapeutics | 8-K: Current report
Sep 19, 2022 07:47 ET
Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Aug 11, 2022 16:11 ET
No Data
No Data